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Abstract
Genomic instability (GIN) and chromosome instability (CIN) are two closely related ways to
produce a variety of pathogenic conditions, i.e. cancer, neurodegeneration, chromosomal and
genomic diseases. The GIN and CIN manifestation that possesses the most appreciable impact on
cell physiology and viability is aneuploidy. The latter has been consistently shown to be associated
with aging. Classically, it has been considered that a failure of mitotic machinery leads to aneuploidy
acquiring throughout aging in dividing cells. Paradoxically, this model is inapplicable for the human
brain, which is composed of post-mitotic cells persisting throughout the lifetime. To solve this
paradox, we have focused on mosaic neural aneuploidy, a remarkable biomarker of GIN and CIN
in the normal and diseased brain (i.e. Alzheimer's disease and ataxia-telangiectasia). Looking
through the available data on genomic variations in the developing and adult human central nervous
system, we were able to propose a hypothesis suggesting that neural aneuploidy produced during
early brain development plays a crucial role of genetic determinant of aging in the healthy and
diseased brain.
Introduction
Aneuploidy has been consistently shown to be associated
with aging [1-5]. However, there is no consensus on how
aneulpoidization and aging are interconnected. Several
lines of evidences indicate that increasing rate of mitotic
errors in late ontogeny can be a mechanism for chromo-
some gains and losses in aging tissues [6]. This corre-
sponds to data on aneuploidy in human tissues
composed of mitotic cells [2-4], but is inapplicable to
post-mitotic cells. In this context, the human brain is
probably the most remarkable example of a tissue popu-
lated by almost exclusively post-mitotic cells that are not
suggested to undergo mitotic division [7,8]. One can
assume a brain aging mechanism without aneuploidiza-
tion, but this is not in accordance with molecular neuro-
cytogenetic observations of the adult human brain
demonstrating the presence of aneuploid cells [9-14]. The
dilemma might be solved by addressing adult neurogene-
sis research that has depicted the possibility of the adult
mammalian brain to generate new neuronal cells [15].
However, these data is unable to provide complete expla-
nation of aging-related changes within the content of
chromosomal DNA in the normal and diseased human
brain, which indicates aneuploidy association with brain
aging phenotypes [7,9-14,16-20]. Nonetheless, the brain
is aging!
At the turn of the last century, there were no less than 300
theories for explanation of aging phenomenon [21]. It is
apparent, that none of these hypotheses would give the
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ultimate explanation of such a complex process. Never-
theless, some theories, especially those aimed to gather
different data from several biomedical areas, appear to be
more "close to the reality". Among these models, there is
one based on cellular/molecular parallels between proc-
esses occurring in senescent and cancer cells [22]. The
commonest pattern of molecular changes observed in
both aging and cancer cell is genomic instability (GIN).
This can manifest at different molecular and microscopic
levels: single nucleotides, nucleotide repeat size varia-
tions, loss/gains of genomic regions, loss of chromosome
structural integrity, structural chromosome abnormali-
ties, aneuploidy or polyploidy. Analysis of cancers and
aged tissues suggests that instability of the nuclear
genome is more frequently involves changes occurring at
chromosomal level. The latter, in some instances, may
manifest as chromosome instability (CIN)
[7,12,17,20,22-26]. Pathological consequences of GIN or
CIN usually become appreciable via  its accumulation
throughout ontogeny [7,12,22,23]. In other words, phe-
notypic consequences of GIN and CIN are not necessarily
immediate. This fact is intriguing in the light of ontoge-
netic variations of aneuploidy rates in the normal human
brain and presence of GIN/CIN in the diseased brain
(especially, in cases of individuals suffering from acceler-
ated aging diseases) [5,7-14,16-20,27,28]. Summarizing
current data on somatic genome behavior in brain, cancer
and aging tissues, it is hard to avoid making some paral-
lels. Similar phenomena (GIN and CIN) occurring in
these biological systems are unlikely to be a simple coin-
cidence. This has led us to an attempt of gathering current
knowledge about GIN and CIN in the human brain to
achieve an integrated view of the interplay between aneu-
ploidy and aging in the human brain. As a result, a
GIN'n'CIN (GIN and CIN) hypothesis connecting data on
these phenomena and brain aging was proposed.
This hypothesis was inspired by recent advances in chro-
mosome research of the human brain or molecular neuro-
cytogenetics of individuals with/without brain diseases.
Among these, there were some associated with accelerated
or abnormal aging. Furthermore, appreciable ontogenetic
variations of CIN levels in the human brain were noticed.
Therefore, to make a clear presentation of our hypothesis,
we found pertinent first to provide a description of brain-
specific GIN/CIN occurrence at different ontogeny stages
and in brain diseases, especially when accompanied by
accelerated aging.
Aneuploidy in the human brain: cell fate and 
ontogeny
It has been long debated whether the mammalian brain is
populated by cells with abnormal chromosome numbers
(polyploid cells) [7,29-31]. However, these observations
were not definitive, inasmuch as there were not a tech-
nique for direct analysis of chromosomes in non-dividing
interphase cells [7,9,12,16]. The breakthrough in develop-
ing new molecular cytogenetic approaches towards analy-
ses of interphase chromosomes has allowed direct
visualization of individual chromosomes in the human
brain. The latter was associated with the introduction of
multiprobe fluorescence in situ hybridization (mFISH),
quantitative fluorescence in situ hybridization (QFISH)
and interphase chromosome-specific multicolor chromo-
some banding (ICS-MCB, the unique technique allowing
analysis of whole interphase chromosomes in their integ-
rity) [5,7,9-14,16-20,27,28,32-35]. As a result, a series of
high-resolution studies targeted at definition of chromo-
some number variations in the normal brain were per-
formed and elucidated aneuploidy to be the essential
source for the genetic intercellular diversification. Table 1
gives an overview of molecular neurocytogenetic data on
aneuploidy the normal human brain obtained by the
aforementioned techniques. The human brain has exhib-
ited relatively high rate of sporadic (stochastic) aneu-
ploidy, taking into account its post-mitotic nature [7-
11,14,19,20,27,28]. Thus, the developing human brain
has been shown to possess about 30% of aneuploidy cells.
This cell number is surprisingly close to the amount of
cells cleared by programmed cell death throughout prena-
tal brain development [7,9,27,28]. Therefore, it was
unsurprising that the adult human brain exhibited aneu-
ploidy rates being almost exactly three-fold less than that
in the developing human brain (Table 1) [7-14,19,20].
These ontogenetic variations of neuronal genome are
undoubtedly determined by the fate of aneuploid brain
cells [7]. There have been provided extensive data on
genetic and epigenetic phenomena that influence neuro-
nal cell fate [8,36]. However, effects of aneuploidy were
not experimentally addressed in this context.
Nevertheless, some considerations can be made according
to current knowledge of aneuploidy effects and associa-
tions in other somatic tissues or accelerated aging disor-
ders [5,7,14,17,20,28,37]. Figure 1 demonstrates the
essential ways, according which the fate of an aneuploid
neuron can develop. Regardless difficulties of making def-
inite conclusions concerning relationship between neuro-
nal cell fate and human brain diseases, it is to recognize
that the failure of neuronal homeostasis and excessive loss
of neurons due to aneuploidy or integration of aneuploid
neurons into neuronal circuitry should negatively affect
the functioning of the human brain. In any case, the pres-
ence of aneuploid neurons is rather pathological sign than
a normal condition. Therefore, extensive aneuploidiza-
tion of neural cells is a highly probable mechanism for
brain diseases. Additionally, aneuploid neurons could beMolecular Cytogenetics 2009, 2:23 http://www.molecularcytogenetics.org/content/2/1/23
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implicated in aging processes. Without direct experimen-
tal proofs, this can be tested addressing brain diseases
associated with accelerated aging.
Diseases of accelerated aging due to unstable 
genome: a neurocytogenetic overview
Currently, there are no fewer than 25 accelerated aging or
progeroid diseases associated with genetic instabilities,
including monogenic and chromosomal diseases [22,38-
40]. The most striking common features that almost all
these disorders possess is referred to CIN/GIN and cancer
susceptibility. A number of these diseases are associated
with neurodegeneration. Usually, such diseases are caused
by mutations in genes involved in maintenance of the
genome integrity or chromosome structure [38,40].
Aneuploidy has long been noticed to produce senescent
cellular phenotype [41]. Therefore, it is not surprising that
the most common aneuploidy syndrome (Down syn-
drome or trisomy of chromosome 21) is associated with
premature aging and neurodegeneration [22,38]. Down
syndrome is uncommonly associated with CIN or chro-
mosomal mosaicism. It is suggested that over 95% of
cases are associated with trisomy 21 affecting all the cells
of the organism (including brain cells) [42,43]. However,
a subtype of this syndrome termed mosaic trisomy 21
exhibiting milder symptoms of Down syndrome does
exist [44]. Additional chromosome 21 has profound
effects on brain functioning and morphology in individu-
als with Down syndrome [37]. The latter provides for a
speculative conclusion that aneuploidy could cause pre-
mature brain aging, but it does not exclude the need of an
experimental proof, which has not been, as yet, provided
[7,12]. Furthermore, mosaic trisomy 21 detected in fetal
ovarian tissues was found to be a likely explanation for
maternally derived aneuploidy in conceptuses of aged
mothers [45]. Nonetheless, neither CIN nor GIN has been
evaluated in the Down syndrome brain. Probably, it
would not exhibit high rate of CIN nor GIN, inasmuch as
trisomy 21 being an already unbalanced chromosome
complement has not been described to produce further
GIN/CIN in human somatic cells. However, related stud-
ies will certainly give hints to aneuploidization theory of
aging.
Regarding aneuploidy association with aging, it is to men-
tion a hypothesis suggesting common origins of Down
syndrome and Alzheimer's disease. More precisely, it has
been proposed that Alzheimer's disease brain pathology is
likely to result from mosaic chromosome 21 aneuploidy
[46]. Subsequent indirect evaluations performed on dif-
ferent Alzheimer's disease models have formed a strong
experimental basis for this hypothesis [47,48]. Moreover,
low-level mosaic aneuploidy of chromosome 21 is repeat-
edly observed in Down syndrome offspring's mothers,
who are susceptible to Alzheimer's disease, as well [49].
Thus, brain-confined aneuploidy has appeared to be
involved in Alzheimer's disease pathogenesis [7]. To test
these assumptions, aneuploidy was monitored in the cer-
ebral cortex of the Alzheimer's disease brain. The study
has shown a dramatic 10-fold increase of chromosome
21-specific aneuploidy and a conclusion that somatic
mosaic aneuploidy of chromosome 21 does play a critical
role in Alzheimer's disease pathogenesis has been made
Table 1: Aneuploidy in the developing and normal adult human brain
Rate of aneuploidy, %
(per chromosome/whole genome)
Evaluation technique References
Developing brain:
direct evaluation 0.6-3.0/~28 mFISH [9]
1.25-1.45/30-35 mFISH/QFISH ICS-MCB [28]
after in vitro cultivation 1.2-7.0/72.4 mFISH [9,27]
Adult brain:
0.1-0.8/~9 mFISH [9,11]
0.2-2/10 ICS-MCB [10]
0.2-0.7/~10 mFISH/QFISH ICS-MCB [14]
Abbreviations: mFISH -- multiprobe fluorescence in situ hybridization; QFISH -- quantitative fluorescence in situ hybridization; ICS-MCB -- 
interphase chromosome-specific multicolor chromosome banding.Molecular Cytogenetics 2009, 2:23 http://www.molecularcytogenetics.org/content/2/1/23
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The fate of an aneuploid neuron Figure 1
The fate of an aneuploid neuron. It seems that there are two most probable ways. Firstly, aneuploid neuron can be inte-
grated into neuronal circuitry. This has the potential to produce disease phenotype (through affecting all the elements of the 
circuitry via synaptic activity of aneuploid neuron) or this could be a probable mechanism of aging; alternatively, if aneuploidy 
rates are relatively low, integration of aneuploid neuron into neuronal circuitry is suggested to be a mechanism for neuronal 
diversity. Secondly, aneuploid neuron can be subjected to neuronal cell death. The latter could be associated with large-scale 
neuronal cell clearance that has potential to lead to brain diseases or, alternatively, to be an aging mechanism.Molecular Cytogenetics 2009, 2:23 http://www.molecularcytogenetics.org/content/2/1/23
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[14]. Together, molecular neurocytogenetic analyses of
Alzheimer's disease suggest aneuploidy to be involved in
brain aging.
Another extraordinary example of a progeroid disease
associated with brain dysfunction and CIN is ataxia-tel-
angiectasia [38,40]. This autosomal recessive disease is
associated with mutations in ATM (a gene involved in
genome maintenance as well as cell cycle regulation and
apoptotic pathways [50]) that are responsible for multilat-
eral CIN in affected individuals [20]. Ataxia-telangiectasia
is characterized by targeted cerebellar neurodegeneration,
oculocutaneous telangiectasia, cancer predisposition,
radiosensitivity, immunodeficiency and progeroid fea-
tures [50]. Clinical and molecular studies of this disease
have brought tremendous advances in molecular and cell
biology of cell cycle, cancerization, immunodeficiency
and aging as well as neurobiology of human disease
[20,50]. The analysis of ataxia-telangiectasia for testing
hypothetic associations between CIN and accelerated
aging becomes even more actual taking into account
appreciable age-dependant changes in functioning of
DNA repair machinery [51]. This disease is also featured
by a paradox that refers to neurodegenerative processes
occurring exclusively in the cerebellum (targeted cerebel-
lar degeneration), while other brain areas are significantly
less affected [52]. The solution of this paradox has been
provided by molecular neurocytogenetic studies that have
indicated selective confinement CIN/GIN to more
severely affected brain areas (cerebellum) and aneuploidi-
zation of brain cells as essential mechanisms for ataxia-
telangiectasia brain dysfunction [14,20]. Paradoxically,
CIN was found to increase with age in the ataxia-tel-
angiectasia brain [20]. Together, this data allows the spec-
ulation that increased CIN and GIN are involved in
accelerated brain aging.
Table 2 summarizes available data on brain-specific GIN/
CIN in accelerated aging diseases. Regardless moderate
amount of such studies, a conclusion about strong associ-
ation between GIN, CIN, and aneuploidy in the brain and
accelerated brain aging is unavoidable. At least, it can be
stated about genetic brain diseases that have been already
studied.
Although other progeroid diseases exhibiting genetic
instabilities are not primarily associated brain dysfunc-
tion [38,40], molecular neurocytogenetic studies of these
syndromes can shed light onto mechanisms of accelerated
brain aging. Since there are numerous parallels between
aging and tumorigenesis, additional valuable data can be
retrieved from the investigation of genetic diseases with
brain cancer predisposition. It is noteworthy that Li-Frau-
meni syndrome, which is associated with mutations in
p53, a global transcription factor involved in cell cycle
control, tumor suppression, apoptosis, etc., is a progeroid
disease featured by a predisposition to the development
of brain tumors [40,53]. Furthermore, a hypothesis that
suggests the lack of clearance of neural cells affected by
GIN and CIN during prenatal brain development to pro-
duce childhood brain tumors appear to be highly proba-
ble [54]. One can propose that similar processes occurring
in late ontogeny are involved in rather non-malignant
neural cell dysfunction and neurodegeneration than tum-
origenesis. Nevertheless, all these issues require addi-
tional molecular neurocytogenetic studies.
GIN'n'CIN hypothesis
The hypothesis is based on the following aforementioned
observations: (i) the developing human brain is prone to
GIN/CIN and this leads to aneuploidization of 30-35% of
fetal brain cells [28]; (ii) aneuploid cells are cleared
throughout normal early brain development, this leads to
decreasing of aneuploidy rate to approximately 10% after
birth [9,10,14]; (iii) abnormal clearance of defected cells
is associated with brain diseases, the majority of which are
also characterized by accelerated (abnormal) aging and
are featured by increased rates of GIN/CIN manifesting as
Table 2: Molecular neurocytogenetic data on accelerated aging diseases
Disease Neurocytogenetic findings CIN GIN References
Down syndrome Presumably 100% (?) of trisomy 21 NS* NS* [37,42,43]
Alzheimer's diseases (AD) Chromosome 21-specific aneuploidy confined to 
degenerated brain areas
+? [ 1 4 ]
AD model 
(transfected human cells with presenelin 1 mutations)
Acquired chromosome missegregation causing aneuploidy + + [46]
Ataxia telangiectasia Aneuploidy; chromosome breakage producing additional 
rearranged chromosomes (partial aneuploidy) confined to 
the degenerated cerebellum
++[ 1 4 , 2 0 ]
*NS -- not studiedMolecular Cytogenetics 2009, 2:23 http://www.molecularcytogenetics.org/content/2/1/23
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aneuploidy or other types of genetic instabilities confined
to the brain [5,7,12,14,16-20]; (iv) the brain has the
potential to produce cell populations affected by GIN,
CIN, or mosaic aneuploidy via mitotic errors during adult
neurogenesis or age-related failures to repair damaged
chromosomal DNA in neuronal cells [51]. Figure 2 sche-
matically presents key points of our hypothesis. As one
can see, there is a paradoxical feature of the human brain.
More precisely, aneuploidization is initiated long before
aging manifestations, leading to aneuploid cells produc-
tion exclusively during early ontogeny. In other words, the
most noticeable accumulation of aneuploid cells and
propagation of CIN happen during the early development
of the brain. In the first trimester of pregnancy, abnormal
cells comprise almost exactly one third of the fetal brain
population [28]. GIN is also shown to accumulate in neu-
ral/progenitor cells of the mammalian brain [55]. Devel-
opmental accumulation of GIN and CIN is similar or even
more extensive as to that occurring in aging mitotic tissues
[56]. However, when becomes composed preferentially of
The key points of the hypothesis Figure 2
The key points of the hypothesis. The developing human brain (12-15 weeks' gestation) exhibit 30-35% of aneuploid cells 
[28], which are formed during neurogenesis (prenatal brain development). This process becomes exhausted soon after birth. 
At later developmental stage, adult neurogenesis starts, being, however, significantly less productive in terms of the amount of 
cells formed. Abnormal clearance of aneuploid cells leads to postnatal brain diseases, which are featured by GIN and CIN con-
fined to the brain. Some of these diseases are associated with accelerated aging (i.e. Alzheimer's disease and ataxia-telangiecta-
sia). Normal brain development leads to decrease of aneuploidy rates, which achieves averagely 10% [9,10,14]. The presence of 
aneuploid cells in the brain from the early prenatal development to the late ontogeny is hypothesized to give rise to GIN and 
CIN in the brain of elderly individuals. This is partially confirmed by analyzing controls in molecular neurocytogenetic studies of 
the diseased brain [5,7,12-14,16-20]. Mitotic errors during adult neurogenesis can also produce aneuploid cells throughout 
aging.Molecular Cytogenetics 2009, 2:23 http://www.molecularcytogenetics.org/content/2/1/23
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post-mitotic cells, the human brain exhibit a decrease of
abnormal cell amount that, nonetheless, affects no fewer
than 100 billion out of one trillion of neural cells
[9,10,14]. Thus, at early ontogeny CIN/GIN rate makes a
burst, then as neurogenesis slows down, aneuploidization
does the same and the rate of CIN/GIN significantly
decreases. If not decreased, both CIN and GIN lead to
clinically distinguished brain diseases [7,14,16-20] (Fig-
ure 2). On the other hand, an appreciable proportion of
aneuploid cells is present in the human brain being com-
parable to aneuploidy in other tissues composed of
mitotic cells in elderly individuals [1-5,7,9-14,16-20].
This suggests that aneuploidy being an aging factor is gen-
erated in early development of the brain and persists
throughout ontogeny. It remains uncertain whether aneu-
ploidy rates vary because of aging. Does the aging pro-
gram launch prior to birth? Is this a genetic program itself
or is this a cascade of program errors due to developmen-
tal GIN/CIN? Although it sounds unusual, there are argu-
ments for such speculations. Firstly, aneuploidy is
associated with senescent cellular phenotype
[7,37,38,40,41]. Secondly, 10% of aneuploid cells
emerged during embryogenesis, among which at least a
small proportion has from 10 to 10000 synapses (contacts
with other brain cells), should possess an adverse effect on
brain functioning [7]. Moreover, analysis of ataxia-tel-
angiectasia murine models and the human ataxia-tel-
angiectasia brain has demonstrated that failed clearance
of aneuploid cells leads to premature aging phenotypes
[20,57]. GIN and CIN leads to function losses or gains of
RNAs and proteins (encoded by hundreds or thousands of
genes localized in lost/gained chromosomes) involved in
diverse cellular processes associated with aging. Together,
it suggests that both GIN and CIN are phenomena
involved in brain aging, but these genetic mechanisms are
not the same as in "mitotic tissues". Since the brain can-
not accumulate somatic chromosome mutations through
mitotic divisions, it is difficult to solve this paradox. Here,
we suggest aneuploidy remaining in the human brain
after developmental cell clearance to be involved in cellu-
lar senescence processes. GIN/CIN initiates "molecular
countdown" that begins long before phenotypic manifes-
tations of brain aging in a manner of "delayed-action
bomb". Therefore, mosaic aneuploidy acquired by the
developing brain can be considered as an initiating ele-
ment of the global genetic brain aging program. Probably,
programmed cell death machinery that clears aneuploid
cells in the developing brain ceases to function soon after
birth. The latter appears to be convenient, because neuro-
genesis is unable to provide sufficient amount of cells to
maintain proper brain cell amount that could be altered
by the presence of aneuploid cells. Therefore, the persist-
ence of aneuploid cells in the brain is rather a compro-
mise between aneuploidization and exhausted
neurogenesis than a required part of neuronal milieu.
Senescent cell phenotypes generated by aneuploidy do
not manifest immediately [41]. Therefore, mosaic aneu-
ploidy can produce age-related changes in the brain after
a period. Likewise, age-related cell loss begins to be
noticeable in elderly individuals [58]. Moreover, neurode-
generative genetic brain diseases such as Alzheimer's dis-
ease, Down syndrome and ataxia-telangiectasia are
featured by abnormal aging, aneuploidy and CIN/GIN
affecting significant cell populations in the brain
[14,20,42].
Does the adult human brain generate aneuploid cells? In
this context, it is to refer to an important intention of cur-
rent neuroscience, i.e. understanding of adult neurogene-
sis. Considering the rate of neuronal cells generated by
this process [15], one can suggest its insignificant input as
into confrontation with cell losses because of aging as into
propagation of GIN/CIN in the aging brain. Nonetheless,
our hypothesis does not completely exclude a contribu-
tion of adult neurogenesis to brain aging. We propose that
mitotic errors during adult neurogenesis produce small
amount of aneuploid brain cells, and this peculiarly con-
tributes to GIN/CIN manifested as increased aneuploidy
in late ontogeny. However, some comments on the hypo-
thetic link between CIN/GIN and neurogenesis in the
adult brain appear to be required. It is to notice that CIN
(and, probably, GIN) is likely to affect non-neuronal
(glial) cells in accelerated aging diseases [14,20]. Conse-
quently, adult neurogenesis is unlikely to contribute sig-
nificantly to age-related brain aneuploidization. One can
immediately identify adult gliogenesis as the most proba-
ble candidate process for the normal and diseased brain
aneuploidization, especially addressing current views sug-
gesting this process to be more widespread than adult
neurogenesis [59]. Nevertheless, adult gliogenesis has not
been genetically studied in the same extent as adult neu-
rogenesis was. Therefore, in the light of our hypothesis,
making definite conclusions about the role of adult neu-
rogenesis/gliogenesis in brain aging is incorrect. However,
since mitotic machinery demonstrates failures because of
aging [6], aneuploidization of cells generated through
adult neurogenesis is possible.
According to our hypothesis, key points of brain aging
mediated by GIN/CIN are as follows:
-- developmental genetic instabilities affecting fetal brain
cells produces GIN and CIN that essentially manifests as
an increase of aneuploidy rates;
-- programmed cell death diminish amount of cells
affected by CIN/GIN during early brain development, but
a significant proportion of aneuploid cells ultimately
remains in the postnatal brain after birth and persists
throughout ontogeny;Molecular Cytogenetics 2009, 2:23 http://www.molecularcytogenetics.org/content/2/1/23
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-- aneuploidy alters homeostasis of neuronal cells, gener-
ates senescent cellular phenotypes and, probably, pro-
motes cell death; these processes begin to be apparent at
phenotypic level in late ontogeny;
-- aneuploidy in the human brain is a unique aging-
related phenomenon: it forms in early development, but
acts as a genetic determinant of cellular senescence.
Concluding remarks
One can argue whether there is a need of another aging
theory. It is usually hard to find out a rationale of this
multilateral process among different suggestions about
the nature of cellular senescence leading to aging pheno-
types. Such skepticism about theoretical considerations
concerning aging hypotheses is unavoidable and suggests
gathering of data from different areas of biomedicine to
give an adequate explanation. Regardless several decades
of cell senescence research, an integrated view on cellular/
molecular basis of the aging is far from being complete
[60]. Furthermore, commonly accepted hypotheses of
aging (i.e. mitotic failure, telomere shortening, replicative
stress etc.) cannot provide complete explanation of brain
aging because of its "post-mitotic nature". Our hypothesis
is not targeted at explanation of aging, as a whole, but is
intended to define the meaning of causal relationship
between aneuploidy and brain cell senescence. It accords
well with observations of brain diseases featured by
abnormal aging and aneuploidy effects on cellular home-
ostasis [14,20,37-42,47,48] as well as to theories of envi-
ronmental effects associated with aging (i.e. effect of free
radicals) [20], aging-cancer parallels [23,60], and somatic
mutation accumulation [55,56]. Interestingly, the latter
theory has been formulated exactly 50 years ago [61] and
has been immediately challenged [62]. Evolutionary
approaches dictated that maintenance of somatic
genomes would not continue throughout the whole
ontogeny leading, thereby, to age-dependent accumula-
tion of somatic mutations [61]. Contrariwise, natural rate
of somatic mutations was suggested to be low for produc-
ing an effect [62]. This discordance became more impor-
tant in context of brain aging and, especially, after
understanding of "post-mitotic nature" of the human
brain. Ontogenetic periods have different somatic muta-
tion rates (i.e. mitotic errors are more frequent during pre-
natal development than during postnatal periods) [7,17].
The present GIN'n'CIN hypothesis can help to solve this
long-standing problem by applying different thresholds
for aneuploidy effects to each ontogeny period and to
each tissue depending on the mitotic activity and pattern
of the organization. To this end, regardless results of forth-
coming experimental testing of this hypothesis, brain
aging should be viewed as an extraordinarily complex bio-
logic phenomenon that conceptually changes our think-
ing about time-scale of biological processes in neural cells
as well as about causal relationship between somatic GIN/
CIN and cellular homeostasis.
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